Cardiac involvement in children with IBD during infliximab therapy [4]

Inflammatory Bowel Diseases

Volumn 12, Issue 8, 2006, Pages 828-829

  Barbato, Maria ^a   Curione, Mario ^a   Viola, Franca ^a   Versacci, Paolo ^a   Parisi, Fabiana ^a   Amato, Silvia ^a   Cucchiara, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

AUTOIMMUNE DISEASE; CAUSE OF DEATH; CROHN DISEASE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFICACY; ENTERITIS; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HUMAN; INFECTION; INJECTION SITE REACTION; LETTER; PATIENT MONITORING; PRIORITY JOURNAL; QT INTERVAL; ULCERATIVE COLITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL; ARRHYTHMIA; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GASTROINTESTINAL AGENTS; HEART FUNCTION TESTS; HEART RATE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747382765     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/00054725-200608000-00021     Document Type: Letter

References (8)

1. Rutgeerts P, Van Assche G, Vermeire S. Review article: infliximab therapy for inflammatory bowel disease, seven years on. Aliment Pharmacol Ther. 2006;23:451-463.
2. Borrelli O, Bascietto C, Viola F, et al. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig Liver Dis. 2004;36:342-347.
3. Mamula P, Markowitz JE, Brown KA, et al. Infliximab as a novel therapy for pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr. 2002;34:307-311.
4. Colombel JF, Loftus EV, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients. Gastroenterology. 2004;126:19-31.
5. Kwon HJ, Cotè TR, Cuffe MS, et al. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med. 2003;138:807-811.
6. Leetmaa TH, Markenvard JD. Dilated cardiomyopathy as a side effect of treatment with infliximab. Ugesker Laeer. 2005;167:3699-3701.
7. Boyer JF. New-onset acute heart failure and ventricular tachycardia after therapy with a tumor necrosis factor antagonist. Clin Exp Rheumatol. 2004;22:274-275.
8. De'Clari F, Salani I, Safwan E, et al. Sudden death in a patient without heart failure after a single infusion of 200 mg infliximab: does TNF-alpha have protective effects on the failing heart, or does infliximab have direct harmful cardiovascular effects? Circulation. 2002;105:183.